This talk was presented at the 2018 SAGES Meeting/16th World Congress of Endoscopic Surgery by Dana M Hayden during the Emerging Treatment for Diverticulitis: Making Sense of the Evidence Amidst the Controversy on April 13 2018
Keyword(s): abdominal, abscess, acute diverticulitis, admissions, American Socity of Colon & Rectal Surgeons, anastomotic leak, antibiotics, ASCRS, atrophy, bone marrow transplant, cancer, chemotherapy, clinical manifestations, colectomy, colonic injury, comorbidities, complicated acute diverticulitis, complicated diverticulitis, corticosteroids, CT scan, death, decision-making, diabetic, diagnosis, diverticular abscess, diverticulosis, diverting ileostomy, drainage, elective colectomy, elective surgery, emergency surgery, emerging treatment, failure rate, fever, Hartmanns procedure, heart transplant, HIV, human immunodeficiency virus, ICU, immunosuppressed, immunosuppression, IMS, inflammatory reaction, intensive care unit, kidney transplant, laparoscopic surgery, length of stay, LOS, lung transplant, macrophages, medical therapy, mortality, NOM, non-operative management, outcomes, perforation, peritoneal dialysis catheter, peritonitis, phlegmon, physical exam, polycystic kidney disease, postop complications, postoperative complications, presentation, prevalence, primary anastomosis, prospective database, recommendations, recurrence, remission, renal failure, renal transplant, reoperation, retrospective analysis, retroviral therapy, RTR, smoker, solid organ transplant, stoma, submucosal lymphoid patches, tachycardia, transplant, waitlisted, Western population, wound dehiscence
Immunosuppression & diverticulitis–51 sec
Populations of IMS–1:40
Prevalence of diverticulitis in IMS–2:03
Different presentations in IMS–2:30
Outcomes by type of IMS–2:54
Corticosteroid therapy–3:57
Diverticulitis & chemotherapy–4:46 Int J Surg 2014
Diverticulitis & renal failure–5:36
Renal transplant recipients–6:12
Lung & cardiac transplant patients–6:45
Diverticulitis & diabetes–7:22
Diverticulitis & HIV–7:53
Overall outcomes: IMS vs IC–8:27
Surgical outcomes–IMS vs IC–8:51
Emergent surgery–9:39 Colorectal Dis 2014
Recurrence–10:22
Decision-making for IMS–11:18
Tx strategy–11:32